These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7933458)

  • 1. Interferon alpha 2a in patients of chronic hepatitis C.
    Zuberi SJ; Alam SE; Raza S
    J Pak Med Assoc; 1994 Jul; 44(7):171-2. PubMed ID: 7933458
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of sustained efficacy of interferon in patients with chronic hepatitis C.
    Vento S; Concia E; Ferraro T
    N Engl J Med; 1996 May; 334(22):1479-80. PubMed ID: 8618600
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithyroid peroxidase antibody and development of silent thyroiditis during interferon-alpha 2a treatment of chronic hepatitis C.
    Wada M; Shimoyama T; Hamada A; Fukuchi M
    Am J Gastroenterol; 1995 Aug; 90(8):1366-7. PubMed ID: 7639264
    [No Abstract]   [Full Text] [Related]  

  • 4. [The treatment of hepatitis B and C with interferon-alpha can induce or aggravate psoriasis].
    Cervoni JP; Serfaty L; Picard O; Imbert JC; Poupon R
    Gastroenterol Clin Biol; 1995 Mar; 19(3):324-5. PubMed ID: 7781955
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of chronic hepatitis C with recombinant interferon alfa.
    Chen YK; Bala K
    West J Med; 1992 Jan; 156(1):72. PubMed ID: 1734608
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy.
    Mels GC; Roffi L; Antonelli G; Bellati G; Pacchetti S; Di Nolfo MA; Panizzuti F; Moretti G; Piperno A; Pozzi M
    Prog Clin Biol Res; 1993; 382():359-64. PubMed ID: 8502704
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon therapy in hepatitis C--refractory hepatitis--report of the research subgroup of treatment of chronic hepatitis.
    Iino S
    Gastroenterol Jpn; 1993 Mar; 28 Suppl 4():139-42. PubMed ID: 8486225
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic hepatitis C and markedly elevated serum alpha-fetoprotein: complete response to treatment with alpha-interferon.
    Weinberg DS; Malet PF
    Am J Gastroenterol; 1994 Aug; 89(8):1253-4. PubMed ID: 7519819
    [No Abstract]   [Full Text] [Related]  

  • 9. [Autoimmune thrombocytopenic purpura after treatment of chronic viral hepatitis C with interferon].
    Maïga MY; Oberti F; Foussard C; Calès P
    Gastroenterol Clin Biol; 1995; 19(8-9):739-40. PubMed ID: 8522132
    [No Abstract]   [Full Text] [Related]  

  • 10. [Esophageal candidiasis during interferon therapy for chronic viral hepatitis C].
    Prignet JM; Galzin M; Demarquay JF; Raynard B; Louvety S; Künkel D
    Gastroenterol Clin Biol; 1994; 18(8-9):796-7. PubMed ID: 7875459
    [No Abstract]   [Full Text] [Related]  

  • 11. [Attempted suicide during treatment of chronic viral hepatitis C with interferon. Apropos of 2 cases].
    Bourat L; Larrey D; Michel H
    Gastroenterol Clin Biol; 1995 Dec; 19(12):1063. PubMed ID: 8729421
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interferon therapy in chronic viral hepatitis].
    Welland O
    Nord Med; 1992; 107(3):72-3, 75. PubMed ID: 1549455
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: life-threatening severe immune thrombocytopenia after alpha-interferon therapy for chronic hepatitis C infection.
    Khan HA; Khawaja FI; Mahrous AR
    Am J Gastroenterol; 1996 Apr; 91(4):821-2. PubMed ID: 8677971
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lichen planus during chronic hepatitis C treated with interferon alpha].
    d'Agay-Abensour L; Benamouzig R; de Belilovsky C; Cordoliani F; Halphen M; Rambaud JC
    Gastroenterol Clin Biol; 1992; 16(6-7):610-1. PubMed ID: 1526425
    [No Abstract]   [Full Text] [Related]  

  • 15. Breakthrough of interferon therapy.
    Scalori A; Ricci A; Bellati G; Colloredo G; Roffi L
    Am J Gastroenterol; 1996 Oct; 91(10):2249-50. PubMed ID: 8855768
    [No Abstract]   [Full Text] [Related]  

  • 16. Why we should treat chronic viral hepatitis.
    King PD
    Postgrad Med; 1996 Sep; 100(3):68-70, 73; discussion 73, 78. PubMed ID: 8795647
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment with recombinant interferon alfa-2a and pregnancy in a patient with chronic viral hepatitis C].
    Masbou J; Larrey D; Michel H
    Gastroenterol Clin Biol; 1995 Nov; 19(11):961-2. PubMed ID: 8746065
    [No Abstract]   [Full Text] [Related]  

  • 18. alpha-Interferon therapy for hepatitis C virus chronic infection with mixed cryoglobulinemia.
    Castilla A; Castilla I; Prieto J
    Am J Gastroenterol; 1993 Mar; 88(3):466-7. PubMed ID: 8438868
    [No Abstract]   [Full Text] [Related]  

  • 19. Abducent nerve paralysis during interferon alpha-2a therapy in a case of chronic active hepatitis C.
    Fukumoto Y; Shigemitsu T; Kajii N; Omura R; Harada T; Okita K
    Intern Med; 1994 Oct; 33(10):637-40. PubMed ID: 7827383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-lymphocyte subpopulations as factors predicting clinical response to interferon in hepatitis C virus-related chronic active hepatitis.
    Guadagnino V; Caroleo B; Izzi A; De Rosa G; D'Amelio R
    Infection; 1995; 23(3):189-90. PubMed ID: 7499011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.